Document is current
Any future updates will be listed below
-
Authors
Gendelman, Isaac
Alibhai, A. Yasin
Moult, Eric M.
Levine, Emily S.
Braun, Phillip X.
Mehta, Nihaal
Zhao, Yi
Ishibazawa, Akihiro
Sorour, Osama A.
Baumal, Caroline R.
Witkin, Andre J.
Reichel, Elias
Fujimoto, James G.
Duker, Jay S.
Waheed, Nadia K. http://orcid.org/0000-0002-8229-7519
-
Funding
Funding for this research was provided by:
Macula Vision Research Foundation
Air Force Office of Scientific Research (FA9550-15-1-0473)
Foundation for the National Institutes of Health (5-R01-EY011289-31)
Massachusetts Lions Eye Research Fund
- License Information
-
More Information
Article History
Received: 14 November 2019
Accepted: 12 February 2020
First Online: 19 March 2020
Ethics approval and consent to participate
: This study was approved by the Institutional Review Board for Tufts Medical Center and all patients provided informed consent.
: Not applicable.
: AI: Topcon Medical Systems, Inc. (Tokyo, Japan) (S), Nidek Medical Products, Inc. (Gamagori, Aichi, Japan) (S) CRB: Carl Zeiss Meditec, Inc. (Dublin, CA, USA) (S), Genentech (South San Francisco, CA, USA), Novartis (Basel, Switzerland) (S), Allergan (Dublin, Ireland) (C) JGF: Topcon Medical Systems Inc. (Oakland, NJ, USA) (C, F), Optovue, Inc. (Fremont, CA, USA) (C, R, S), Carl Zeiss Meditec, Inc. (Dublin, CA, USA) (R) JSD: Carl Zeiss Meditec, Inc. (Dublin, CA, USA) (C, F), Optovue, Inc. (Fremont, CA, USA) (C, F) NKW: Macula Vision Research Foundation (West Conshohocken, PA, USA) (F), Topcon Medical Systems, Inc. (Oakland, NJ, USA) (F), Nidek Medical Products, Inc. (Fremont, CA, USA) (S, F), Optovue, Inc. (Fremont, CA, USA) (C), Carl Zeiss Meditec, Inc. (Dublin, CA, USA) (F) ER: Regeneron Pharmaceuticals, Inc. (Tarrytown, NY, USA) (F).
